Health
Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle COVID-19 Vaccine – The Korea Herald
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory…
– Novavax and Serum Institute of India file regulatory submissions to the Drugs Controller General of India and to regulatory agencies in Indonesia and Philippines for Novavax’ recombinant nanoparticle COVID-19 vaccine
– Filing for World Health Organization…
-
Noosa News23 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News23 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General16 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business16 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?